EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Protective effect of low‐intensity pulsed ultrasound on immune checkpoint inhibitor-related myocarditis via fine-tuning CD4+ T-cell differentiation

Shuai Fu, Zihong Guo, Xiangli Xu, Yifei Li, Stephen Choi, Peng Zhao, Wenqian Shen, Fei Gao, Chao Wang, Shuang Chen, You Li, Jiawei Tian und 1 weitere

Cancer Immunology, Immunotherapy · 2024

DOI: 10.1007/s00262-023-03590-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2024. Verfasst von Shuai Fu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China. Hauptthemen laut MEDLINE: Myocarditis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Immune checkpoint inhibitors (ICIs) have transformed traditional cancer treatments. Specifically, ICI-related myocarditis is an immune-related adverse event (irAE) with high mortality. ICIs activate CD4 + T-lymphocyte reprogramming, causing an imbalance between Th17 and Treg cell differentiation, ultimately leading to myocardial inflammatory damage. Low-intensity pulsed ultrasound (LIPUS) can limit inflammatory responses, with positive therapeutic effects across various cardiovascular inflammatory diseases; however, its role in the pathogenesis of ICI-related myocarditis and CD4 + T-cell dysfunction remains unclear. Accordingly, this study investigated whether LIPUS can alleviate ICI-related myocarditis inflammatory damage and, if so, aimed to elucidate the beneficial effects of LIPUS and its underlying molecular mechanisms.

Methods

An in vivo model of ICI-related myocarditis was obtained by intraperitonially injecting male A/J mice with an InVivoPlus anti-mouse PD-1 inhibitor. LIPUS treatment was performed via an ultrasound-guided application to the heart via the chest wall. The echocardiographic parameters were observed and cardiac function was assessed using an in vivo imaging system. The expression of core components of the HIPPO pathway was analyzed via western blotting.

Results

LIPUS treatment reduced cardiac immune responses and inflammatory cardiac injury. Further, LIPUS treatment alleviated the inflammatory response in mice with ICI-related myocarditis. Mechanistically, in the HIPPO pathway, the activation of Mst1–TAZ axis improved autoimmune inflammation by altering the interaction between the transcription factors FOXP3 and RORγt and regulating the differentiation of Treg and Th17 cells.

Conclusion

LIPUS therapy was shown to reduce ICI-related myocarditis inflammatory damage and improve cardiac function, representing an exciting finding for irAEs treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MyocarditisMaleAnimalsMiceImmune Checkpoint InhibitorsCell DifferentiationLymphocyte ActivationCD4-Positive T-Lymphocytes

Stichwörter der Autor:innen

HIPPOImmune checkpoint inhibitorsLow-intensity pulsed ultrasoundMyocarditisProgrammed death 1

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Ultrasound, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China.
  • Ultrasound Molecular Imaging Joint Laboratory of Heilongjiang Province, Harbin, Heilongjiang Province, China.
  • The Key Laboratory of Myocardial Ischemia, Harbin Medical University, Ministry of Education, Harbin, Heilongjiang Province, China.
  • Department of Ultrasound, The Second Hospital of Harbin, Harbin, Heilongjiang Province, China.
  • SXULTRASONIC Ltd. Kerry Rehabilitation Medicine Research Institute, Shenzhen, Guangdong Province, China.
  • Department of Ultrasound, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China. jwtian2004@163.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Fu, S., Guo, Z., Xu, X., Li, Y., Choi, S., Zhao, P., Shen, W., Gao, F., Wang, C., Chen, S., Li, Y., Tian, J., & Sun, P. (2024). Protective effect of low‐intensity pulsed ultrasound on immune checkpoint inhibitor-related myocarditis via fine-tuning CD4+ T-cell differentiation. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-023-03590-5

Vancouver

Fu S, Guo Z, Xu X, Li Y, Choi S, Zhao P, et al. Protective effect of low‐intensity pulsed ultrasound on immune checkpoint inhibitor-related myocarditis via fine-tuning CD4+ T-cell differentiation. Cancer Immunology, Immunotherapy. 2024. doi:10.1007/s00262-023-03590-5

BibTeX
@article{Fu2024,
  author = {Fu, Shuai and Guo, Zihong and Xu, Xiangli and Li, Yifei and Choi, Stephen and Zhao, Peng and Shen, Wenqian and Gao, Fei and Wang, Chao and Chen, Shuang and Li, You and Tian, Jiawei and Sun, Ping},
  title = {Protective effect of low‐intensity pulsed ultrasound on immune checkpoint inhibitor-related myocarditis via fine-tuning CD4+ T-cell differentiation},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2024},
  doi = {10.1007/s00262-023-03590-5}
}
Kostenlos starten →